48 results on '"Hao, Xinbao"'
Search Results
2. Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling
3. Evaluation of the clinical application effect of eSource record tools for clinical research
4. MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications
5. Treatment of multiple myeloma with selinexor: a review
6. Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990–2017
7. Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas
8. Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147
9. Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis
10. Supplementary Figure 1 from HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
11. Supplementary Tables 2 - 4 from HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
12. Supplementary Table 5 from HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
13. Supplementary Data from Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase as an Anticancer and Radiosensitizing Target
14. Supplementary Figure 2 from HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
15. Supplementary Figures 5 - 6 from HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
16. Supplementary Figure 4 from HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
17. Supplementary Figure 3 from HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
18. Supplementary Table 1 from HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
19. Purification and Analysis of the CREPT Antibody from Mouse Ascites
20. The metronomic therapy with prednisone, etoposide, and cyclophosphamide reduces the serum levels of VEGF and circulating endothelial cells and improves response rates and progression-free survival in patients with relapsed or refractory non-Hodgkin’s lymphoma
21. CREPT Accelerates Tumorigenesis by Regulating the Transcription of Cell-Cycle-Related Genes
22. Additional file 1 of Evaluation of the clinical application effect of eSource record tools for clinical research
23. Cardiolipin Remodeling by ALCAT1 Links Oxidative Stress and Mitochondrial Dysfunction to Obesity
24. MicroRNA‑145 promotes the apoptosis of leukemic�stem�cells and enhances drug‑resistant K562/ADM cell�sensitivity to adriamycin via the regulation of ABCE1
25. Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas
26. Exploratory Study on the Relationship Between FcγRIIIa Gene Polymorphisms and the Efficacy and Toxicity of Rituximab in the Treatment of Stage I/II Diffuse Large B-Cell Lymphoma
27. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
28. MicroRNA-145 promotes the apoptosis of leukemic stem cells and enhances drug-resistant K562/ADM cell sensitivity to adriamycin via the regulation of ABCE1.
29. LncRNA FUNDC2P4 down-regulation promotes epithelial–mesenchymal transition by reducing E-cadherin expression in residual hepatocellular carcinoma after insufficient radiofrequency ablation
30. Apatinib alone or combined with radiotherapy in metastatic prostate cancer: Results from a pilot, multicenter study
31. LncRNA FUNDC2P4 down-regulation promotes epithelial-mesenchymal transition by reducing E-cadherin expression in residual hepatocellular carcinoma after insufficient radiofrequency ablation.
32. First-in-human, phase I study of KC1036, a multiple kinase inhibitor, as a single agent in patients with advanced solid tumors.
33. Antibody Against CD44s Inhibits Pancreatic Tumor Initiation and Postradiation Recurrence in Mice
34. HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
35. SNX25 regulates TGF-β signaling by enhancing the receptor degradation
36. Homozygous intronic mutation leading to inefficient transcription combined with a novel frameshift mutation in F13A1 gene causes FXIII deficiency
37. Abstract 2458: MicroRNA miR-34 as a natural regulator and potential therapeutic for pancreatic cancer stem cells
38. Abstract 565: Anti-CD44 antibody treatment inhibits pancreatic cancer metastasis and post-radiotherapy recurrence
39. A novel function of the human CLS1 in phosphatidylglycerol synthesis and remodeling
40. Abstract 2084: Tumor suppressor microRNA miR-34 inhibits human pancreatic cancer stem cells
41. Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase as an Anticancer and Radiosensitizing Target
42. Abstract A53: Tumor suppressor microRNA miR‐34 inhibits human pancreatic and gastric cancer stem cells
43. MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
44. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
45. Repurposing niclosamide as a novel anti-SARS-Cov-2 drug by restricting entry protein CD147.
46. [Effect of siRNA targeting PML-RARa fusion gene on activity of the acute promyelocytic leukemia cell line NB4].
47. Specific antitumor effects of tumor vaccine produced by electrofusion between osteosarcoma cell and dendritic cell in rats.
48. [Identification of genes associated with human osteosarcoma metastasis suppression using suppression subtractive hybridization].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.